Lysophosphatidic Acid Receptor 1 Specifically Labels Seizure-Induced Hippocampal Reactive Neural Stem Cells and Regulates Their Division by Valcárcel Martín, Roberto et al.
fnins-14-00811 November 11, 2020 Time: 12:6 # 1
BRIEF RESEARCH REPORT
















†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Neurogenesis,
a section of the journal
Frontiers in Neuroscience
Received: 27 March 2020
Accepted: 10 July 2020
Published: 14 August 2020
Citation:
Valcárcel-Martín R,
Martín-Suárez S, Muro-García T,
Pastor-Alonso O,
Rodríguez de Fonseca F,
Estivill-Torrús G and Encinas JM
(2020) Lysophosphatidic Acid
Receptor 1 Specifically Labels
Seizure-Induced Hippocampal
Reactive Neural Stem Cells
and Regulates Their Division.
Front. Neurosci. 14:811.
doi: 10.3389/fnins.2020.00811
Lysophosphatidic Acid Receptor 1
Specifically Labels Seizure-Induced
Hippocampal Reactive Neural Stem
Cells and Regulates Their Division
Roberto Valcárcel-Martín1,2†, Soraya Martín-Suárez1†, Teresa Muro-García1,2,
Oier Pastor-Alonso1,2, Fernando Rodríguez de Fonseca3, Guillermo Estivill-Torrús4 and
Juan Manuel Encinas1,2,5*
1 The Neural Stem Cell and Neurogenesis Laboratory, Achucarro Basque Center for Neuroscience, Leioa, Spain,
2 Department of Neurosciences, University of the Basque Country (UPV/EHU), Leioa, Spain, 3 Unidad de Gestión Clínica de
Salud Mental, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga,
Spain, 4 Unidad de Gestión Clínica de Neurociencias, Hospital Regional Universitario de Málaga, Instituto de Investigación
Biomédica de Málaga (IBIMA), Málaga, Spain, 5 Ikerbasque, The Basque Foundation for Science, Bilbao, Spain
A population of neural stem cells (NSCs) dwelling in the dentate gyrus (DG) is able
to generate neurons throughout adult life in the hippocampus of most mammals. These
NSCs generate also astrocytes naturally and are capable of generating oligodendrocytes
after gene manipulation. It has been more recently shown that adult hippocampal NSCs
after epileptic seizures as well as subventricular zone NSCs after stroke can give rise
to reactive astrocytes (RAs). In the hippocampus, the induction of seizures triggers
the conversion of NSCs into reactive NSCs (React-NSCs) characterized by a drastic
morphological transformation, abnormal migration, and massive activation or entry into
the cell cycle to generate more React-NSCs that ultimately differentiate into RAs. In the
search for tools to investigate the properties of React-NSCs, we have explored the
LPA1–green fluorescent protein (GFP) transgenic line of mice in which hippocampal
NSCs are specifically labeled due to the expression of lysophosphatidic acid receptor
1 (LPA1). We first addressed the validity of the transgene expression as true marker
of LPA1 expression and then demonstrated how, after seizures, LPA1-GFP labeled
exclusively React-NSCs for several weeks. Then React-NSCs lost LPA1-GFP expression
as neurons of the granule cell layer started to express it. Finally, we used knockout for
LPA1 transgenic mice to show that LPA1 plays a functional role in the activation of React-
NSCs. Thus, we confirmed that LPA1-GFP expression is a valid tool to study both NSCs
and React-NSCs and that the LPA1 pathway could be a target in the intent to preserve
NSCs after seizures.
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INTRODUCTION
New neurons are generated postnatally and into adulthood in the dentate gyrus (DG) of the
hippocampus of the majority of mammals (Altman and Das, 1965; Bonfanti and Peretto, 2011).
Adult hippocampal neurogenesis (AHN) is maintained, thanks to a population of astrocyte-like and
radial glia-like neural stem cells (NSCs) with neurogenic (Seri et al., 2001) and gliogenic potential
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(Encinas et al., 2011). The population of hippocampal NSCs
dwells specifically in the subgranular zone (SGZ) and generates
neurons that get integrated into the granule cell layer (GCL).
Adult hippocampal neurogenesis has been described to be
involved in spatial learning (Zhang et al., 2008), memory (Farioli-
Vecchioli et al., 2008), and forgetting (Akers et al., 2014).
Moreover, the lack of AHN associates with increased anxiety
and altered the responses to stress and fear (Saxe et al., 2006;
Bergami et al., 2008; Snyder et al., 2011). Finally, antidepressant
drugs present neurogenesis-dependent effects (Sharma et al.,
2007; David et al., 2009; Perera et al., 2011). The properties
of NSCs determine the neurogenic and gliogenic output of
the DG in normal and pathological conditions. Hippocampal
NSCs are mostly quiescent, and only a small fraction (around
2%) is actively cycling in a given moment (Kronenberg et al.,
2003; Encinas et al., 2006). Because gliogenic or neurogenic
differentiation following entry into the cell cycle is the main
factor driving the depletion of the NSC pool (Bonaguidi
et al., 2011; Encinas et al., 2011; Pilz et al., 2018), regulation
of the quiescence/activation equilibrium is key to sustained
neurogenesis throughout adulthood as self-renewing symmetric
division does not compensate exhaustion in vivo (Bonaguidi et al.,
2011; Pilz et al., 2018). Neuronal activity tightly regulates NSC
activation through excitatory and inhibitory neuronal input to
NSCs (Song et al., 2012; Yeh et al., 2018).
We recently showed how in mouse models of mesial
temporal lobe epilepsy (MTLE) hippocampal seizures induced
by intrahippocampal (Sierra et al., 2015) or intra-amygdalar
(Muro-García et al., 2019) injection of the glutamate receptor
agonist kainic acid (KA) strongly affect NSCs. Seizures trigger a
dramatic switch in the phenotype and function of NSCs. Shortly
after the initial episode of seizures, NSCs convert into reactive
NSCs (React-NSCs) that are characterized by several features:
(1) they transform into a more complex multibranched shape and
overexpress the neuroectodermal stem cell marker (nestin) and
the glial fibrillary acidic protein (GFAP); (2) they detach from
the SGZ and migrate into the GCL; (3) they get activated in large
numbers switching to a symmetric mode of division to generate
more React-NSCs; and (4) they finally transform, after 4–6 weeks,
into S100β-positive reactive astrocytes (RAs) morphologically
indistinguishable from astrocyte-derived RAs. Thus, React-NSCs
represent a novel pathophysiological cell fate of NSCs that we
aim to investigate.
One of the major problems to study the properties of NSCs
and, in our case, React-NSCs is the lack of pure specific
biomarkers. Traditional markers such as GFAP, sex determining
region Y-box 2 (Sox2), vimentin, brain lipid-binding protein,
and others are also expressed by astrocytes and RAs, thus
making biomarker-based identification of NSCs and React-
NSCs difficult. Recently, the lysophosphatidic acid receptor 1
(LPA1) has been reported as a new specific marker of adult
NSCs. A transgenic mouse line in which the enhanced green
fluorescent protein expression (GFP) driven by LPA1 (LPA1-
GFP) expression labels hippocampal NSCs has been described
(Walker et al., 2016). We herein investigated whether LPA1-
GFP mice could be a useful tool to identify and investigate
React-NSCs. Further, LPA1 has been linked to regulation of
neurogenic process. The brain of a mouse strain lacking LPA1,
the Málaga variant of LPA1-null (maLPA1-null), has shown
defects in cortical layer width and reduced proliferation and
neurogenesis in the adult DG (Estivill-Torrus et al., 2008; Matas-
Rico et al., 2008). Also, the endogenous ligand LPA induced
AHN in vivo (Walker et al., 2016). We have here used the
maLPA1 mice in our model of MTLE to investigate whether
it plays a role in the seizure-induced transformation of NSCs
into React-NSCs.
MATERIALS AND METHODS
For an extended description of methods, see section “Materials
and Methods” and “Supplementary Materials and Methods”
in Supplementary Material.
Animals
Lysophosphatidic acid receptor 1–GFP transgenic mice,
generated by the GENSAT project at Howard Hughes Medical
Institute (The Rockefeller University, NY, United States) (Gong
et al., 2003), were provided by Dr. Gerd Kempermann at
the Center for Regenerative Therapies Dresden (Technische
Universität Dresden, Dresden, Germany) and crossbred with
C57BL/6 mice for at least 10 generations. maLPA1-null mice
(Estivill-Torrus et al., 2008), derived from previously reported
LPA1-null mice (Contos et al., 2000), and their wild-type (WT)
counterparts (on a mixed background C57BL/6 × 129SW) were
kindly provided by Guillermo Estivill-Torrús at the Instituto de
Investigación Biomédica de Málaga (IBIMA, Hospital Regional
Universitario de Málaga, Málaga, Spain). All procedures were
approved by the University of the Basque Country (UPV/EHU)
Ethics Committees (Leioa, Spain) and Diputación Foral de
Bizkaia under protocol M20/2015/236. All procedures followed
the European directive 2010/63/UE and National Institutes of
Health guidelines.
5-Bromo-2′-Deoxyuridine Administration
5-Bromo-2′-deoxyuridine (BrdU) was administered
intraperitoneally (four injections 2 h apart) on the second
day after the intrahippocampal injection.
Immunohistochemistry and Cell
Quantification
Immunostaining of brain slices, image capture, and quantitative
analysis were performed essentially as described before following
methods optimized for their use in transgenic mice (Encinas
et al., 2011; Sierra et al., 2015; Muro-García et al., 2019).
Model of MTLE (The Stereotaxic
Intrahippocampal Injection of KA)
We followed the protocol optimized and described in Sierra
et al. (2015), Abiega et al. (2016), and Bielefeld et al.
(2017). We used the coordinates anteroposterior 1.8 mm,
laterolateral 1.6 mm, and dorsoventral 1.9 mm taken from
Bregma (Franklin and Paxinos, 1997). Controls were injected
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with 50 nL of saline and MTLE mice with 20 mM KA (1 nmol)
dissolved in saline.
Statistical Analysis
For analyses involving more than two groups, a one-way analysis
of variance (ANOVA) was performed (postnatal and neuronal
expression of LPA1-GFP). When evaluating the time× treatment
interaction in the LPA1-GFP time course, a two-way ANOVA was
employed, and analyses continued when normality assumptions
were fulfilled. When comparing two groups (integrated density)
a Mann-Whitney U test was used. Otherwise data were
transformed into logarithmic scale. Post hoc Holm–Sidak test
followed in all cases.
RESULTS
A previous description of the LPA1-GFP transgenic line of mice
showed the specificity of LPA1-GFP expression for marking
the NSC population of the adult hippocampus (Walker et al.,
2016). In order to validate the bona fide expression of GFP in
LPA1-expressing cells, we used immunostaining with an anti-
LPA1 antibody. We first used the anti-LPA1 antibody in tissue
from WT mice and from Málaga LPA1-null mice, (maLPA1-
null mice), previously characterized (Estivill-Torrus et al., 2008).
Staining in the WT mice labeled NSCs in the hippocampus,
whereas staining was almost absent in the maLAP1-null sections
(Figures 1A,B). Neural stem cells were identified because of
their unique morphology and location. Their soma is located
along the SGZ between the hilus and the GCL, and a single
apical process extends though the GCL toward the molecular
layer. There it branches profusely in a broccoli-like arborization.
Light staining was found in the maLPA1-null mice because
a residual level of a truncated form of LPA1 is expressed
(Figure 1B). We next validated the specificity of the expression
of GFP by assessing the localization of LPA1 immunostaining
in brain sections from LPA1-GFP mice. We confirmed that
the vast majority of LPA1-GFP+ NSCs expressed LPA1, thus
confirming the reliable correspondence between LPA1-GFP
and endogenous LPA1 expression (Figures 1C–H) in normal
conditions. Importantly, no other cell type expressed LPA1-GFP
in the hippocampus. These results are in agreement with an
aging-related study in which we tested the expression of the
LPA1 protein in 8 month-old nestin-GFP mice and showed
that more than 90% of nestin-GFP+/GFAP+ NSCs costained
with the anti-LPA1 antibody (Martín-Suárez et al., 2019).
Noteworthy, immunohistochemistry for the LPA1 required a
specific fixation protocol (see Materials and Methods) that
was not compatible with staining for most of the antibodies
used in this study. This issue underscores the usefulness of
the LPA1-GFP transgenic line of mice. We next analyzed the
expression of LPA1-GFP in early postnatal and young mice
and found that LPA1 is absent from radial nestin-expressing
NSCs located in SGZ and GCL in newborn mice, starting in
postnatal day 4 (P4), but its expression increased gradually
over time until it was present in the vast majority of them by
P14 (Supplementary Figures 1A,B). Interestingly, an abundant
population of LPA1-GFP–expressing neurons (colocalizing with
the neuronal marker NeuN) was found in P4 in the hilus
(Supplementary Figure 1C). In an opposite fashion to NSCs,
hilar neurons lost LPA1-GFP expression over time, and it was
almost absent by P14.
Our main hypothesis is that seizure-induced React-NSCs
could keep expressing LPA1 that could be therefore a useful
specific marker of this cell type. Thus, we designed a time-
course experiment in which LPA1-GFP mice were subjected to
the hippocampal model of MTLE (a single intrahippocampal
injection of KA). On the second day after they were given
four intraperitoneal injections of 150 mg/kg of BrdU (2 h
apart). Mice were then sacrificed on the third day or after
1, 2, 3, 6, or 10 weeks. As reported before, the presence of
normal NSCs with typical radial morphology was negligible
in the DG of the MTLE mice (Figures 2A,B). In the MTLE
mice, LPA1-GFP cells with reactive morphology (Figures 2B,D)
were located mainly in the SGZ and the GCL. Granule cell
layer dispersion with a subsequent narrowing of the hilus is
a hallmark of human and experimental MTLE. As a result,
LPA1-eGFP–expressing cells occupy a broader area of the DG
in MTLE mice than in control ones. Noteworthy, LPA1-GFP
expression was absent in the molecular layer, in which RAs
are induced by MTLE. We observed that React-NSCs kept
expressing LPA1-GFP but that no other cell type did in the
earlier time points (Figures 2A–C) as LPA1-GFP expression
was restricted to GFAP+ cells located in the SGZ and GCL.
The overall number of LPA1-GFP+GFAP+ cells in MTLE
mice was significantly higher than in control mice during the
time course, especially at the earliest time points. It, however,
decreased over time being even lower than controls by 6 weeks
(Figure 2E). In agreement with our previous reports, React
NSCs, labeled with LPA1-GFP+, entered cell division with a
much higher rate than control NSCs from intrahippocampally
saline-injected mice (Figures 2C,D). The total number of LPA1-
GFP+GFAP+BrdU+ cells was significantly much higher in
MTLE than in saline mice, although it decreased overtime
and was close to controls after 10 weeks (Figures 2C,D,F).
The proportion of BrdU+/LPA1-GFP+/GFAP+ among the total
LPA1-GFP+/GFAP+ was significantly much higher in MTLE
mice than in controls, and interestingly, it increased over
time (Figure 2G).
Importantly, we compared the expression of LPA1 by
immunostaining with that of LPA1-GFP in the MTLE model
(a single injection of KA into the hippocampus and analysis
3 days later). Lysophosphatidic acid receptor 1–GFP+ NSCs
in the control mice and MTLE-induced React-NSCs were
immunostained for LPA1 (Figures 2B, 3A,B). The labeling was
restricted to the SGZ and the GCL and was absent in the rest
of the areas of the DG, suggesting that even in the MTLE mice
no other cell type such as astrocytes or RAs expressed LPA1.
In addition, the expression of GFP and of LPA1 (measured by
intensity of the fluorescent signal) was significantly increased in
MTLE mice compared to control ones (Figures 3C,D). These
results further validate the expression of GFP in LPA1-GFP mice
as a reliable correlate of LPA1 expression. Although we did
not detect LPA1-GFP+ cells outside the SGZ and the GCL, for
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FIGURE 1 | Lysophosphatidic acid receptor 1–GFP expression colocalizes with LPA1 immunostaining and specifically labels hippocampal NSCs. Immunostaining
with an anti-LPA1 antibody labels NSCs in the DG (A). When the same antibody is used in the maLPA1-null mouse, in which only a truncated non-functional form of
LPA1 is expressed, staining is almost absent (B). Immunostaining with the anti-LPA1 antibody in slices from the LPA1-GFP transgenic mouse shows almost total
colocalization. Confocal microscopy imaging was used to analyze colocalization in z-stack projections of the LPA1-GFP signal (C) with the anti-LPA1 immunostaining
(D). DAPI staining was used for better anatomical resolution (E). The merged image is shown in (F), and an orthogonal projection demonstrating full colocalization is
shown in (G). The quantification showing the almost 100% colocalization of LPA1-GFP and LPA1 immunostaining in NSCs is shown in (H). Scale bar is 20 µm in all
images.
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FIGURE 2 | Lysophosphatidic acid receptor 1–GFP expression is maintained in seizure-induced React-NSCs. Control and MTLE mice were administered BrdU (four
injections, 2 h apart) on the second day after surgery for the saline/KA intrahippocampal injection and then sacrificed 3 days or 1, 2, 3, 6, or 10 weeks after surgery.
Expression of LPA1-GFP is restricted to GFAP-expressing NSCs in the SGZ in the control mice (A) and to GFAP-expressing React-NSCs located in the SGZ or GCL
in the MTLE mice (B). In the molecular layer, GFAP-expressing astrocytes did not express LPA1-GFP as shown by z-stack projections obtained by confocal
microscopy. The time-course analysis with BrdU costaining at higher magnification (C,D) shows an overall increase in the number of LPA1-GFP+GFAP+ cells in early
time points and a later decline (E). The number of BrdU+ LPA1-GFP+GFAP+ cells is much higher in MTLE mice in every time point, but it decreases in the later ones
(F). The percentage of BrdU+ LPA1-GFP+GFAP+ follows an opposite trend as it increases over time, although it is also much higher than in controls in all time points
(G). Scale bar is 50 µm in (A,B) and 10 µm in (C,D). Data were analyzed by a two-way ANOVA. Post hoc Holm–Sidak was used to analyze differences between
time points and sal vs. MTLE. Only the differences between sal vs. MTLE in each time are shown. *p < 0.05, **p ≤ 0.005, ***p ≤ 0.001.
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FIGURE 3 | Neural stem cells in sal-injected (A, left) and React-NSCs in MTLE LPA1-GFP mice (B, right) express LPA1 (3 days after surgery) as demonstrated by
immunostaining with anti-LPA1 antibody. No other cell types were labeled with either LPA1-GFP or anti-LPA1 antibody in control or MTLE mice (B). The expression of
LPA1-GFP (C) or LPA1 (D) was significantly increased in MTLE-induced React-NSCs compared to control NSCs as measured by the integrated density of the
fluorescent signal. (E) shows the combination of biomarker expression that can be used to differentially identify NSCs, React-NSCs, astrocytes, and RAs. Scale bar
is 10 µm in (A) and 50 in µm (B). Data were analyzed by a Mann-Whitney U test. Graphs show individual data and mean ± SEM. ***p ≤ 0.001.
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example, the molecular layer where reactive gliosis takes place,
we wanted to confirm that RAs did not express LPA1-GFP using
S100β as a differential marker (Figure 3E). We injected LPA1-
GFP mice with a single dose of KA in the cortex (cx) where
in normal condition there is no expression of LPA1-GFP and
analyzed them 3 days later. The injection of KA triggered reactive
astrogliosis as visualized by immunostaining for GFAP and S100β
(Supplementary Figures 3A,B). No expression of LPA1-GFP
(Supplementary Figures 3A,B) or of LPA1 by immunostaining
(Supplementary Figure 3C) was found in the cx of either control
or KA mice. This result rules out that astrocytes could start the
expression of LPA1-GFP when they transform into RAs after
an excitotoxic insult. As positive controls for the staining, we
checked the DG in the same slices for expression of GFAP, S100β,
and LPA1-GFP (Supplementary Figures 3D,E). For positive
immunostaining of LPA1 (see Figures 2A,B). A scheme of the
combination of biomarkers that differentially identify NSCs,
React-NSCs, astrocytes and RAs is provided in Supplementary
Figure 2E. Astrocytes express GFAP and S100β but not nestin
(or nestin-GFP) or LPA1-GFP. Finally, RAs express nestin (and
nestin-GFP), GFAP, and S100β, but not LPA1-GFP.
These results strongly suggest that the expression of LPA1-
GFP is indeed a specific marker of React-NSCs, at least
for 2 weeks, but later they gradually lose the expression
of LPA1-GFP/GFAP as they convert into RAs. As we have
previously reported (Sierra et al., 2015), astrocytes do not
increase their low rate of cell division in MTLE, and close to
zero GFAP+GFP− cells incorporated BrdU (data not shown).
Most of the BrdU+ cells were indeed GFAP+GFP+, which
allows us to rely on BrdU staining to trace the differentiation
of LPA1-GFP+ cells. As expected, LPA1-GFP+/GFAP+ did
not express S100β in the earlier time points (Supplementary
Figure 3A). Over time, the percentage of LPA1-GFP+/GFAP+
cells expressing also S100β increased gradually so that most of
the remaining LPA1-GFP+/GFAP+ cells expressed S100β after
10 weeks (Supplementary Figures 3B–D).
Another noticeable finding from the time course is that
after several weeks neurons in the GCL started to express
LPA1-GFP (Supplementary Figures 4A–C) only in the MTLE
mice. Although staining was less intense than that of React-
NSCs, the proportion of granule cells (colabeled with the
neuronal marker NeuN) increased over time after 2 weeks so
that approximately 25% of all neurons in the GCL expressed
LPA1-GFP 10 weeks after the KA injection (Supplementary
Figure 4D). Colocalization of LPA1-GFP with NeuN was absent
in the control mice. Lysophosphatidic acid receptor 1–GFP–
positive neurons were located throughout the GCL without any
particular location (Supplementary Figure 4B), and we did not
find colocalization of LPA1-GFP+/NeuN+ neurons with BrdU
(data not shown). These observations suggest that preexistent
mature granule cells are the ones that start to express LPA1 rather
than newborn ones.
Given the specific expression of LPA1-GFP and LPA1 in
NSCs and in seizure-induced React-NSCs in the short term,
we wondered whether LPA1 could play a role in the induction
of React-NSCs. For this purpose, we used the maLPA1-
null described above (Figure 1). We subjected WT and
maLPA1-null mice to saline or KA intrahippocampal injection
and administered BrdU during the second day after surgery (four
injections, 2 h apart). Mice were then sacrificed 3 days or 2 weeks
after the surgery, and slices were stained for BrdU, GFP, and
GFAP (Figures 4A,B). We first quantified the number of NSCs in
control WT and maLPA1-null mice 3 days and 2 weeks after the
surgery to make sure that the basal population of NSCs was not
altered because of the constitutive lack of LPA1 (Supplementary
Figure 4E). After 3 days, cell proliferation, measured as the
number of BrdU+ cells in the DG, did not change in the maLPA1-
null saline-injected mice compared to the WT saline-injected
ones (Figure 4A). Three days after the saline or KA injection,
the total number of BrdU+ cells was the same in saline mice
(WT and maLPA1-null) but was significantly increased in both
MTLE groups. There was, however, a significantly lower number
of dividing cells in the maLPA1-null MTLE mice compared to
the WT MTLE mice (Figure 4C). Two weeks after the injection,
the results were similar to the 3-dpi point, but the difference
between WT MTLE and maLPA1-null MTLE mice was much
larger (Figure 4D). We then quantified the proportion of dividing
(BrdU+) NSCs (saline) or React-NSCs (MTLE mice) at 3 days
or 2 weeks after saline or KA injection. At 3 dpi, there was no
difference between saline WT or maLPA1-null mice. In the MTLE
mice, the proportion of dividing React-NSCs was significantly
higher than in the saline mice only in the WT mice, but not in the
maLPA1-null animals. Accordingly, there was a smaller fraction
of GFP+GFAP+BrdU+ in the MTLE maLPA1-null mice than
in the MTLE WT ones (Figure 4E). At 2 weeks post-injection,
results were similar to the previous time point, with MTLE
maLPA1-null mice having a significantly reduced proportion
of BrdU+-labeled cells than MTLE WT mice, although in this
case both were higher than in any of the saline-injected mice
(Figure 4F). We conclude that, indeed, the expression of LPA1
regulates (at least in a cell-autonomous manner) NSC division in
pathological conditions and that it could be targeted to prevent
massive activation of seizure-induced React-NSCs.
DISCUSSION
With the overall purpose of characterizing the transformation
from hippocampal NSCs to React-NSCs and finally into RAs
induced by seizures, we searched for new tools that selectively
labeled this cell lineage. There has been a lack of specific markers
for adult hippocampal NSCs, and this is one of the reasons why
the characterization of their properties was elusive for many
years after the discovery of adult hippocampal neurogenesis.
Nestin, the protein “specifically expressed in neuroepithelial
stem cells” (Lendahl et al., 1990), is the most used marker of
NSCs, especially through the development of transgenic mice,
which express GFP under the regulatory elements of nestin
(Yamaguchi et al., 2000; Mignone et al., 2004). Nestin, however,
is expressed also in the neurogenic precursors born from NSCs
besides other cell types outside the neurogenic cascade such
as NG2-positive oligodendrocyte progenitor cells and pericytes
(Yamaguchi et al., 2000; Filippov et al., 2003; Encinas et al.,
2011). Furthermore, the expression of nestin is one of the most
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FIGURE 4 | Absence of LPA1 reduces the massive activation of React-NSCs. WT and maLPA1-null mice were subjected to the model of MTLE (or the
corresponding control) and then were administered BrdU (four injections, 2 h apart) on the second day after the saline/KA intrahippocampal injection. The mice were
sacrificed 3 days or 2 weeks after surgery. We proceeded to quantify the total number of BrdU cells in the DG (A) and the proportion of dividing (BrdU+) NSCs and
React-NSCs (B) by confocal microscopy. The number of BrdU cells was much higher in MTLE mice, but it was reduced in the maLPA1 compared to the WT at 3
days (C). These differences were more evident at the 2-week time point (D). At 3 days, the proportion of dividing (BrdU+) NSCs among total NSCs (identified by
expression of nestin and GFAP) did not change in the control (saline) group. In MTLE WT mice the proportion of dividing NSCs was much higher than in any sal
group but was reduced (without difference to sal levels) in the MTLE maLPA1-null mice (E). 2 weeks after the induction of MTLE, the number of dividing NSCs in the
MTLE maLPA1-null mice was also significantly reduced compared to the MTLE WT mice (F), although in this case both MTLE groups were higher than the sal
groups. Scale bar is 50 mm in (A) and 20 mm in (B). Data were analyzed by a two-way ANOVA. Post hoc Holm–Sidak was used to analyze differences between WT,
maLPA1-null, sal, and MTLE groups. *p < 0.05, **p ≤ 0.005, ***p ≤ 0.001.
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characteristic properties of RAs (Clarke et al., 1994). Thus, the
identification of NSCs, and especially of the RA-looking React-
NSCs in conditions in which the generation of RAs is induced
such as MTLE, can be troublesome. Recently, two new lines
of transgenic mice have been characterized in which specific
labeling of hippocampal NSCs has been reported. One is the
Lfng-eGFP, in which lunatic fringe drives the expression of the
enhanced GFP (Semerci et al., 2017), and the other is the LPA1-
GFP based on the expression of LPA1 (Walker et al., 2016).
We have herein used the LPA1-GFP transgenic line of mice to
further validate its expression in LPA1-expressing cells (through
anti-LPA1 immunostaining in WT and maLPA1 mice). We have
also characterized the onset of its expression in postnatal NSCs
and tested the hypothesis that it could be also a good marker
of React-NSCs. Under pathological conditions such as seizures
(Sierra et al., 2015; Muro-García et al., 2019) or stroke (Faiz
et al., 2015) adult-brain NSCs generate RAs at the expense
of their neurogenic potential. In the hippocampus, in models
of MTLE and before differentiating into RAs, hippocampal
NSCs transform into React-NSCs, different from both normal
NSCs and RAs. React-NSCs divide in much higher rate than
NSCs and overexpress nestin and GFAP as RAs do, but in
contrast, they do not express S100β at least for 4 weeks after
the onset of seizures (Sierra et al., 2015; Muro-García et al.,
2019). We have also confirmed that reactive astrogliosis induced
by an excitotoxic insult (injection of KA in the cx) does not
induce the expression of LPA1 or LPA1-GFP. In other words,
RAs do not express LPA1-GFP as we anticipated by the lack
of expression of LPA1 or LPA1-GFP outside the SGZ and
GCL in control and MTLE mice. We have here described
how React-NSCs overexpress LPA1 and LPA1-GFP early after
the induction of seizures and keep expressing LPA1-GFP for
several weeks, whereas no other cell type does. Later, as they
transform into RAs and the expression of S100β starts, they
lose the expression of LPA1-GFP. This is an important finding
because it tells us that at least for several weeks React-NSCs
are different from NSCs and from RAs and that indeed we can
use LPA1-GFP as a specific marker of React-NSCs to further
explore their properties in the future. The combination of
biomarkers that (together with morphology) can be used to
unequivocally identify NSCs, React-NSCs, astrocytes, and RAs
is summarized in Supplementary Figure 2D). Interestingly, as
the expression of LPA1-GFP is downregulated in React-NSCs, it
becomes upregulated in neurons of the GCL. Lysophosphatidic
acid receptor expression could play a role in neuronal function
as its activation by gintonin has been reported to enhance
both excitatory and inhibitory synaptic transmission in the
adult rat hippocampus (Park et al., 2015). More related to
our study, LPA signaling has been proposed to play a role
in the regulation of KA-induced cell death, although this was
especially observed in CA3 and the receptor whose expression
was affected in the DG was LPA3 and not LPA1 (Lee et al.,
2014). In this same line, the analysis of mouse KA-induced
epileptic seizure models has demonstrated notable changes of
LPA levels in dorsal hippocampus at acute seizure phase (Lerner
et al., 2018). For the moment, we can only speculate LPA1
expression could be part of the group of pathological hallmarks
of MTLE such as GCL dispersion and that could be related to
neuronal cell damage.
Regarding the role of LPA1 in hippocampal neurogenesis,
brains of the maLPA1-null mice show defects in proliferation
in the DG and neurogenesis (Estivill-Torrus et al., 2008;
Matas-Rico et al., 2008). Furthermore, in vivo administration of
the endogenous ligand LPA promoted neurogenesis in vivo
(Walker et al., 2016). We have, however, not found differences
in the basal population of NSCs, suggesting that the alterations
would be due to changes in the mitotic capabilities of NSCs
and progenitors. We have here used the maLPA1-null mice in
our model of MTLE to address its functional role within the
neurogenic niche in pathological conditions. We found that
the lack of LPA1 indeed prevented the massive activation (cell
division) of React-NSCs (measured 3 days or 2 weeks after
MTLE), which translated in an overall reduced number of BrdU+
cells in the DG 2 weeks after the induction of MTLE. An overall
effect in cell proliferation was not noticed in the earliest time
point (3 days after MTLE) most likely because the impact on
React-NSCs division was not enough to make an impact on
overall cell division. Thus, we conclude that LPA1 is particularly
expressed in NSCs and seizure-indeed React-NSCs and that it acts
as a specific marker for React-NSCs at least for 3 to 4 weeks,
before they differentiate into RAs, and neurons of the GCL
start to express it. Further, we show that LPA1 plays a role in
one of the key features of React-NSCs, their massive activation
due to neuronal hyperexcitation. This finding opens the door
to the possibility of targeting LPA1 to preserve the population
of NSCs in MTLE.
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